Chembio and Prionics Sign License Agreement; Deal Has Potential to Generate $2 Million in Milestone and Royalty Payments for Chembio.
Business Wire › February 15, 2005
Linked as:
Extract
Chembio and Prionics Sign License Agreement; Deal Has Potential to Generate $2 Million in Milestone and Royalty Payments for Chembio.
MEDFORD, N.Y. -- Chembio Diagnostics, Inc., (OTCBB: CEMI - News), today announced that it has entered into a license and technology transfer agreement w...
See the full content of this document
Sponsored links
